Alaunos Therapeutics | ZIOP

Stock Price
2.16
Daily Change
0 0%
Monthly
-23.94%
Yearly
-10.74%
Q3 Forecast
2.14

Peers Price Chg Day Year Date
Celltrion 169,000.00 -1,200.00 -0.71% -11.61% Sep/05
Cspc Pharmaceutical 11.19 0.36 3.32% 140.13% Sep/05
Sino Biopharmaceutical 8.91 0.52 6.20% 183.76% Sep/05
Zhangzhou Pientzehuang Pharmaceutical 203.87 0.94 0.46% 0.69% Sep/05
Kangmei Pharma 2.03 0 0% 15.34% Sep/05
Adcock Ingram Holdings 7,187.00 -13.00 -0.18% 10.77% Sep/05
Amgen 283.64 3.54 1.26% -11.49% Sep/05
AstraZeneca 12,090.00 -98.00 -0.80% -4.89% Sep/06
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Biogen 140.67 0.73 0.52% -30.02% Sep/05
Bioline Rx 3.67 0.12 3.38% -85.05% Sep/05
Bristol-Myers Squibb 47.14 0.45 0.96% -3.28% Sep/05
Corcept Therapeutics 69.36 -0.01 -0.01% 101.75% Sep/05
Divis Laboratories Ltd 6,009.00 -124.50 -2.03% 16.96% Sep/05
Gilead Sciences 115.05 2.28 2.02% 46.10% Sep/05
GlaxoSmithKline 1,476.00 7.00 0.48% -10.63% Sep/05
Knight Therapeutics 6.44 0 0% 14.18% Sep/05
Incyte 86.64 1.20 1.40% 41.43% Sep/05
Ionis Pharmaceuticals 61.23 1.88 3.17% 30.58% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Dianthus Therapeutics 26.50 1.84 7.46% -0.45% Sep/05
Malin Corporation 8.00 0 0% 29.03% Sep/01
Merck 84.71 0.66 0.79% -28.14% Sep/05
Medical Developments International 0.58 -0.01 -0.86% 36.90% Sep/05
Neuren Pharmaceuticals 20.48 0.50 2.50% 51.03% Sep/05
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Organigram Holdings 2.28 0.08 3.64% -4.20% Sep/05
Pfizer 24.88 0.34 1.39% -12.95% Sep/05
Pharma Mar 88.40 -2.80 -3.07% 116.88% Sep/05
PTC Therapeutics 57.26 -0.75 -1.29% 81.55% Sep/05
Qiagen NV 40.39 0.18 0.44% -1.38% Sep/06
Regeneron Pharmaceuticals 573.38 6.16 1.09% -49.30% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Laboratorios Farma 59.65 -0.10 -0.17% -26.18% Sep/05
Sartorius 193.20 4.90 2.60% -23.42% Sep/06
TG Therapeutics 32.21 0.32 1.00% 46.21% Sep/05
Tilray 1.64 0.06 3.80% -25.45% Sep/05
Alaunos Therapeutics 2.16 0 0% -10.74% Sep/05

Indexes Price Day Year Date
USND 21700 -7.31 -0.03% 30.01% Sep/05
US2000 2391 11.44 0.48% 14.33% Sep/05

Alaunos Therapeutics Inc traded at $2.16 this Friday September 5th. Looking back, over the last four weeks, Alaunos Therapeutics lost 23.94 percent. Over the last 12 months, its price fell by 10.74 percent. Looking ahead, we forecast Alaunos Therapeutics Inc to be priced at 2.14 by the end of this quarter and at 2.09 in one year, according to Trading Economics global macro models projections and analysts expectations.

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies to deliver cell- and viral-based therapies for the treatment of cancer and graft-versus-host-disease. It has developed an adenoviral vector, Ad-RTS-IL-12, which is administered intra-tumorally under the control of the RheoSwitch Therapeutic System (RTS) expression platform. Its initial clinical stage product candidate, which is being developed using the immuno-oncology platform is Ad-RTS-IL-12 + veledimex. Ad-RTS-IL-12 + veledimex uses its gene delivery system to produce interleukin-12. As of December 31, 2016, it had completed two Phase II studies evaluating Ad-RTS-IL-12 + veledimex, for the treatment of metastatic melanoma and metastatic breast cancer.